Cite Filings / APRE / 0001558370-21-015053

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Aprea Therapeutics, Inc. Filed 2021-11-08 Acc 0001558370-21-015053

Documents 1

10-Q Quarterly Report , apre-20210930x10q.htm

Around this filing

2022-05-16 10-Q Quarterly Report
2021-11-09 S-8 Securities Offered to Employees in Benefit Plans
2021-11-08 10-Q Quarterly Report
2021-11-08 8-K Results of operations
2021-11-03 4 SVP, Chief Business Officer sold 27,500 shares at $5.00 ($137,500)
2021-08-12 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading apre-20210930x10q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…